Previous Close | 2.0000 |
Open | 2.2500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 10.00 |
Expire Date | 2025-01-17 |
Day's Range | 1.9500 - 2.2500 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Company earns Gold Seal of Approval® for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its wholly-owned subsidiary, USARAD Holdings, Inc., a leading provider of teleradiology services, has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation for the sixth time by demonstrating con
PETACH TIKVA, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announces that Company management will participate in three investor conferences in the month of May 2024: EF Hutton 2024 Annual Global ConferenceAGP 2024 Healthcare ConferenceBenchmark 2024 Healthcare House Call Virtual Conference About EF Hutton 2024 Annual Global Conference Nanox’s Chief Executive Officer, Erez Meltzer, and
PETACH TIKVA, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (“SEC”) on April 22, 2024. The annual report on Form 20-F, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC’s website at ht